{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:59:12Z","timestamp":1791097152637,"version":"4.1.0"},"reference-count":39,"publisher":"EDP Sciences","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1051\/medsci\/20102611950","type":"journal-article","created":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T14:04:33Z","timestamp":1298988273000},"page":"950-959","source":"Crossref","is-referenced-by-count":33,"title":["R\u00e9sistance aux carbap\u00e9n\u00e8mes chez les bacilles \u00e0 Gram n\u00e9gatif"],"prefix":"10.1051","volume":"26","author":[{"given":"Patrice","family":"Nordmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"250","published-online":{"date-parts":[[2010,11,15]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-\u03b2-lactamases: the quiet before the storm?Clin Microbiol Rev2005 ; 18 : 306-25.","DOI":"10.1128\/CMR.18.2.306-325.2005"},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Giamarellou H, Poulakou G. Multidrug-resistant Gram-negative infections: what are the treatment options?Drugs2009 ; 69 : 1879-901.","DOI":"10.2165\/11315690-000000000-00000"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Nordmann P, Cuzon G, Naas T. The real threat ofKlebsiella pneumoniacarbapenemase-producing bacteria.Lancet Infect Dis2009 ; 9 : 228-36.","DOI":"10.1016\/S1473-3099(09)70054-4"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Poirel L, Pitout JD, Nordmann P. Carbapenemases: molecular diversity and clinical consequences.Future Microbiol2007 ; 2 : 501-12.","DOI":"10.2217\/17460913.2.5.501"},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Queenan AM, Bush K. Carbapenemases: the versatile \u03b2-lactamases.Clin Microbiol Rev2007 ; 20 : 440-58.","DOI":"10.1128\/CMR.00001-07"},{"key":"R6","unstructured":"Rossolini GM, Mantengoli E, Docquier JD,et al.Epidemiology of infections caused by multiresistant gram-negatives: ESBL, MBL, panresistant strains.New Microbiol2007 ; 30 : 332-9."},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Martinez-Martinez L. Extended-spectrum beta-lactamases and the permeability barrier.Clin Microbiol Infect2008 ; 14 (Suppl 1) : 82-9.","DOI":"10.1111\/j.1469-0691.2007.01860.x"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Doumith M, Ellington MJ, Livermore DM, Woodford N. Molecular mechanisms disrupting porin expression in ertapenem-resistantKlebsiellaandEnterobacterspp. clinical isolates from the UK.J Antimicrob Chemother2009 ; 63 : 659-67.","DOI":"10.1093\/jac\/dkp029"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Lee K, Yong D, Choi YS,et al.Reduced imipenem susceptibility inKlebsiella pneumoniaeclinical isolates with plasmid-mediated CMY-2 and DHA-1 \u03b2-lactamases co-mediated by porin loss.Int J Antimicrob Agents2007 ; 29 : 201-6.","DOI":"10.1016\/j.ijantimicag.2006.09.006"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Lartigue MF, Poirel L, Poyart C,et al.Ertapenem resistance ofEscherichia coli. Emerg Infect Dis2007 ; 13 : 315-7.","DOI":"10.3201\/eid1302.060747"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Carmeli Y, Akova M, Cornaglia G,et al.Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control.Clin Microbiol Infect2010 ; 16 : 102-11.","DOI":"10.1111\/j.1469-0691.2009.03115.x"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S,et al.Predictors of carbapenem-resistantKlebsiella pneumoniaeacquisition among hospitalized adults and effect of acquisition on mortality.Antimicrob Agents Chemother2008 ; 52 : 1028-33.","DOI":"10.1128\/AAC.01020-07"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Miriagou V, Cornaglia G, Edelstein M,et al.Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues.Clin Microbiol Infect2010 ; 16 : 112-22.","DOI":"10.1111\/j.1469-0691.2009.03116.x"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Samra Z, Bahar J, Madar-Shapiro L,et al.Evaluation of CHROMagar KPC for rapid detection of carbapenem-resistantEnterobacteriaceae. J Clin Microbiol2008 ; 46 : 3110-1.","DOI":"10.1128\/JCM.00249-08"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Carr\u00ebr A, Poirel L, Yilmaz M,et al.Emerging spread of OXA-48-encoding plasmid from Turkey and beyond.Antimicrob Agents Chemother2010 ; 54 :1369-73.","DOI":"10.1128\/AAC.01312-09"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"G\u00fclmez D, Woodford N, Palepou MF,et al.Carbapenem-resistantEscherichia coliandKlebsiella pneumoniaeisolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss.Int J Antimicrob Agents2008 ; 31 : 523-6.","DOI":"10.1016\/j.ijantimicag.2008.01.017"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Uzun O, Hascelik G, Livermore DM. Carbapenem-resistantEscherichia coliandKlebsiella pneumoniaeisolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss.Int J Antimicrob Agents2008 ; 31 : 523-6.","DOI":"10.1016\/j.ijantimicag.2008.01.017"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Poirel L, H\u00e9ritier C, Nordmann P. Chromosome-encoded ambler class D \u03b2-lactamase ofShewanella oneidensisas a progenitor of carbapenem-hydrolyzing oxacillinase.Antimicrob Agents Chemother2004 ; 48 : 348-51.","DOI":"10.1128\/AAC.48.1.348-351.2004"},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Walsh TR. Clinically significant carbapenemases: an update.Curr Opin Infect Dis2008 ; 21 : 367-71.","DOI":"10.1097\/QCO.0b013e328303670b"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Lartigue MF, Poirel L, Nordmann P. First detection of a carbapenem-hydrolyzing metalloenzyme in anEnterobacteriaceaeisolate in France.Antimicrob Agents Chemother2004 ; 48 : 4929-30.","DOI":"10.1128\/AAC.48.12.4929-4930.2004"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Rodriguez-Martinez JM, Nordmann P, Fortineau N, Poirel L. VIM-19, a metallo-\u03b2-lactamase with increased carbapenemase activity fromEscherichia coliandKlebsiella pneumoniae. Antimicrob Agents Chemother2010 ; 54 : 471-6.","DOI":"10.1128\/AAC.00458-09"},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Yong D, Toleman MA, Giske CG,et al.Characterization of a new metallo-\u03b2-lactamase gene, b\/a(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure inKlebsiella pneumoniaesequence type 14 from India.Antimicrob Agents Chemother2009 ; 53 : 5046-54.","DOI":"10.1128\/AAC.00774-09"},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Kumarasamy KK, Toleman MA, Walsh TR,et al.Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study.Lancet Infect Dis2010 ; 10 : 597-602.","DOI":"10.1016\/S1473-3099(10)70143-2"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Strateva T, Yordanov D.Pseudomonas aeruginosa- a phenomenon of bacterial resistance.J Med Microbiol2009 ; 58 : 1133-48.","DOI":"10.1099\/jmm.0.009142-0"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Mesaros N, Nordmann P, Pl\u00e9siat P,et al. Pseudomonas aeruginosa:resistance and therapeutic options at the turn of the new millennium.Clin Microbiol Infect2007 ; 13 : 560-78.","DOI":"10.1111\/j.1469-0691.2007.01681.x"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Toleman MA, Simm AM, Murphy TA,et al.Molecular characterization of SPM-1, a novel metallo-\u03b2-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme.J Antimicrob Chemother2002 ; 50 : 673-9.","DOI":"10.1093\/jac\/dkf210"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Rodriguez-Martinez JM, Poirel L, Nordmann P. Molecular epidemiology and mechanisms of carbapenem resistance inPseudomonas aeruginosa. Antimicrob Agents Chemother2009 ; 53 : 4783-8.","DOI":"10.1128\/AAC.00574-09"},{"key":"R28","unstructured":"Nordmann P, Poirel L.Acinetobacter baumannii:Basic and emerging mechanisms of resistance.Eur Infect Dis2009 ; 2 : 94-7."},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Poirel L, Naas T, Nordmann P. Diversity, epidemiology, and genetics of class D \u03b2-lactamases.Antimicrob Agents Chemother2010 ; 54 : 24-38.","DOI":"10.1128\/AAC.01512-08"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Higgins PG, Poirel L, Lehmann M,et al.OXA-143, a novel carbapenem-hydrolyzing class D \u03b2-lactamase inAcinetobacter baumannii. Antimicrob Agents Chemother2009 ; 53 : 5035-8.","DOI":"10.1128\/AAC.00856-09"},{"key":"R31","doi-asserted-by":"crossref","unstructured":"Towner KJ.Acinetobacter: an old friend, but a new enemy. JHosp Infect2009 ; 73 : 355-63.","DOI":"10.1016\/j.jhin.2009.03.032"},{"key":"R32","doi-asserted-by":"crossref","unstructured":"Thomson JM, Bonomo RA. The threat of antibiotic resistance in Gram- negative pathogenic bacteria: \u03b2-lactams in peril!Curr Opin Microbiol2005 ; 8 : 518-24.","DOI":"10.1016\/j.mib.2005.08.014"},{"key":"R33","doi-asserted-by":"crossref","unstructured":"Perez F, Hujer AM, Hujer KM,et al.Global challenge of multidrug-resistantAcinetobacter baumannii. Antimicrob Agents Chemother2007 ; 51 : 3471-84.","DOI":"10.1128\/AAC.01464-06"},{"key":"R34","unstructured":"Desphande P, Rodrigues C, Shetty A,et al.New Delhi metallo \u03b2-lactamase (NDM-1) inEnterobacteriaceae; treatment options with carbapenems compromised.J Assoc Physicians India2010 ; 58 ; 1-6."},{"key":"R35","doi-asserted-by":"crossref","unstructured":"Karthikeyan K, Thirunarayan MA, Krishnan P. Coexistence ofblaOXA-23 with blaNDM-1 andarmAin clinical isolates ofAcinetobacter baumanniifrom India.J Antimicrob Chemother2010 ; 65 : 2253-4.","DOI":"10.1093\/jac\/dkq273"},{"key":"R36","doi-asserted-by":"crossref","unstructured":"Poirel L, Lagrutta E, Taylor P,et al.Emergence of metallo-\u03b2-lactamase NDM-1-producing multidrug resistantEscherichia coliin Australia.Antimicrob Agents Chemother2010 ; 54 : 4914-6.","DOI":"10.1128\/AAC.00878-10"},{"key":"R37","doi-asserted-by":"crossref","unstructured":"Zahar JR, Bille E, Schnell D,et al.Diffusion communautaire des ent\u00e9robact\u00e9ries s\u00e9cr\u00e9trices de P-lactamase \u00e0 spectre \u00e9largi (EBLSE).Med Sci (Paris)2009 ; 25 : 939-44.","DOI":"10.1051\/medsci\/20092511939"},{"key":"R38","doi-asserted-by":"crossref","unstructured":"Pag\u00e8s JM. Porines bact\u00e9riennes et sensibilit\u00e9 aux antibiotiques.Med Sci (Paris)2004 ; 20 : 346-51.","DOI":"10.1051\/medsci\/2004203346"},{"key":"R39","doi-asserted-by":"crossref","unstructured":"Barbier F, Wolff M. Multir\u00e9sistance chezPseudomonas aeruginosa.Vers l\u2019impasse th\u00e9rapeutique ?MedSci (Paris)2010 ; 26 : 960-8.","DOI":"10.1051\/medsci\/20102611960"}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/20102611950\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T18:24:13Z","timestamp":1560018253000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/20102611950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":39,"journal-issue":{"issue":"11"},"alternative-id":["medsci20102611p950"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/20102611950","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}